| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |